Azitra downsizes proposed IPO to $8M from $12M (NYSE:AZTR)

Home » Azitra downsizes proposed IPO to $8M from $12M (NYSE:AZTR)
Initial public offering hologram, night panoramic city view of Bangkok. The financial center for multinational corporations in Asia. The concept of boosting the growth by IPO process. Double exposure.

Azitra downsizes proposed IPO to $8M from $12M (NYSE:AZTR)

2d illustrations and photos/iStock via Getty Images

Dermatology drug developer Azitra (NYSE:AZTR) has downsized its proposed initial public offering to $8M from $12M.

The biotech company said in a filing that it is now looking to offer 1.5M shares priced between $4.50 and $5.50, which would raise nearly $8M if priced

Original article

Click here to view the original article


Share on facebook
Share on twitter
Share on pinterest
Share on linkedin
On Key

Related Posts

Wells Fargo shares tumble after net interest income falls short of estimates

Wells Fargo WFC Q2 2024 earnings

Wells Fargo on Friday reported a 9% decline in net interest income, even though its second-quarter earnings and revenue exceeded Wall Street expectations. Here’s what